Loading...
Header Logo
Keywords
Last Name
Institution

Deirdra Renae Terrell

TitleProf,Asoc
InstitutionUniversity of Oklahoma Health Sciences Center
DepartmentBiostatistics & Epidemiology
Phone405/271-4222
vCardDownload vCard

    Collapse Biography 
    Collapse education and training
    University of Oklahoma Health Sciences Center, Oklahoma City, OKPhD08/2008Epidemiology

    Collapse Research 
    Collapse research activities and funding
    K01HL135466     (TERRELL, DEIRDRA R)Apr 18, 2017 - Mar 31, 2022
    NIH/NHLBI
    Life after Recovery in Adult Thrombotic Thrombocytopenic Purpura (TTP): Let's Hear It from the Survivors
    Role: Co-Investigator

    U54GM104938     (JAMES, JUDITH A)Sep 1, 2013 - Jun 30, 2023
    NIH/NIGMS
    Oklahoma Shared Clinical and Translational Resources
    Role: Associate Director of Translating Practice into Research & Co-Director of Summer Research Training P

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Denson LE, Terrell DR, Vesely SK, Peck JD, Quiroz LH, Shobeiri SA. The Prevalence of Pelvic Floor Hematoma After Vaginal Delivery. Female Pelvic Med Reconstr Surg. 2020 Jun 10. PMID: 32541297.
      View in: PubMed
    2. Izcovich A, Cuker A, Kunkle R, Neumann I, Panepinto J, Pai M, Seftel M, Cheung MC, Lottenberg R, Byrne M, Plovnick R, Terrell D, Holter-Chakrabarty JL, Djulbegovic B, Hicks LK, Wiercioch W, Nieuwlaat R, Schünemann HJ. A user guide to the American Society of Hematology clinical practice guidelines. Blood Adv. 2020 May 12; 4(9):2095-2110. PMID: 32396622.
      View in: PubMed
    3. Neunert C, Terrell DR, Arnold DM, Buchanan G, Cines DB, Cooper N, Cuker A, Despotovic JM, George JN, Grace RF, Kühne T, Kuter DJ, Lim W, McCrae KR, Pruitt B, Shimanek H, Vesely SK. American Society of Hematology 2019 guidelines for immune thrombocytopenia. Blood Adv. 2019 12 10; 3(23):3829-3866. PMID: 31794604.
      View in: PubMed
    4. Terrell DR, Tolma EL, Stewart LM, Shirley EA. Thrombotic thrombocytopenic purpura patients' attitudes toward depression management: A qualitative study. Health Sci Rep. 2019 Oct; 2(11):e136. PMID: 31768419.
      View in: PubMed
    5. van Dorland HA, Taleghani MM, Sakai K, Friedman KD, George JN, Hrachovinova I, Knöbl PN, von Krogh AS, Schneppenheim R, Aebi-Huber I, Bütikofer L, Largiadèr CR, Cermakova Z, Kokame K, Miyata T, Yagi H, Terrell DR, Vesely SK, Matsumoto M, Lämmle B, Fujimura Y, Kremer Hovinga JA. The International Hereditary Thrombotic Thrombocytopenic Purpura Registry: key findings at enrollment until 2017. Haematologica. 2019 10; 104(10):2107-2115. PMID: 30792199.
      View in: PubMed
    6. Reese JA, Peck JD, Yu Z, Scordino TA, Deschamps DR, McIntosh JJ, Terrell DR, Vesely SK, George JN. Platelet sequestration and consumption in the placental intervillous space contribute to lower platelet counts during pregnancy. Am J Hematol. 2019 01; 94(1):E8-E11. PMID: 30328633.
      View in: PubMed
    7. Reese JA, Peck JD, Deschamps DR, McIntosh JJ, Knudtson EJ, Terrell DR, Vesely SK, George JN. Platelet Counts during Pregnancy. N Engl J Med. 2018 Jul 05; 379(1):32-43. PMID: 29972751.
      View in: PubMed
    8. Pishko AM, Misgav M, Cuker A, Cines DB, George JN, Vesely SK, Terrell DR. Management of antithrombotic therapy in adults with immune thrombocytopenia (ITP): a survey of ITP specialists and general hematologist-oncologists. J Thromb Thrombolysis. 2018 Jul; 46(1):24-30. PMID: 29582213.
      View in: PubMed
    9. Martinez SA, Beebe LA, Thompson DM, Wagener TL, Terrell DR, Campbell JE. A structural equation modeling approach to understanding pathways that connect socioeconomic status and smoking. PLoS One. 2018; 13(2):e0192451. PMID: 29408939.
      View in: PubMed
    10. Martinez SA, Beebe LA, Terrell DR, Thompson DM, Campbell JE. Tobacco Use Patterns among GED Recipients. J Health Care Poor Underserved. 2018; 29(4):1488-1508. PMID: 30449759.
      View in: PubMed
    11. Uhl L, Kiss JE, Malynn E, Terrell DR, Vesely SK, George JN. Rituximab for thrombotic thrombocytopenic purpura: lessons from the STAR trial. Transfusion. 2017 10; 57(10):2532-2538. PMID: 28671324.
      View in: PubMed
    12. Page EE, Kremer Hovinga JA, Terrell DR, Vesely SK, George JN. Thrombotic thrombocytopenic purpura: diagnostic criteria, clinical features, and long-term outcomes from 1995 through 2015. Blood Adv. 2017 Apr 11; 1(10):590-600. PMID: 29296701.
      View in: PubMed
    13. Page EE, Kremer Hovinga JA, Terrell DR, Vesely SK, George JN. Clinical importance of ADAMTS13 activity during remission in patients with acquired thrombotic thrombocytopenic purpura. Blood. 2016 10 27; 128(17):2175-2178. PMID: 27625362.
      View in: PubMed
    14. Terrell DR, Reese J, Branesky D, Lu K, Watson SI, Thachil J, Vesely SK, George JN. Depression in adult patients with primary immune thrombocytopenia. Am J Hematol. 2016 10; 91(10):E462-3. PMID: 27434706.
      View in: PubMed
    15. Page EE, Jiang Y, Terrell DR, Vesely SK, George JN. Long-term outcomes of health-related quality of life following diverse thrombotic microangiopathy syndromes. Am J Hematol. 2016 Jun; 91(4):E278-9. PMID: 26822687.
      View in: PubMed
    16. Janssens A, Rodeghiero F, Anderson D, Chong BH, Boda Z, Pabinger I, Cervinek L, Terrell DR, Wang X, Franklin J. Changes in bone marrow morphology in adults receiving romiplostim for the treatment of thrombocytopenia associated with primary immune thrombocytopenia. Ann Hematol. 2016 Jun; 95(7):1077-87. PMID: 27130310.
      View in: PubMed
    17. Page EE, Kremer Hovinga JA, Terrell DR, Vesely SK, George JN. Rituximab reduces risk for relapse in patients with thrombotic thrombocytopenic purpura. Blood. 2016 06 16; 127(24):3092-4. PMID: 27060171.
      View in: PubMed
    18. Terrell DR, Stewart LM, Tolma EL, McClain R, Vesely SK, James JA. Barriers And Motivators for Smoking Cessation in Patients With Systemic Lupus Erythematosus (SLE). J Okla State Med Assoc. 2015 Nov; 108(11):492-9. PMID: 26817068.
      View in: PubMed
    19. Han B, Page EE, Stewart LM, Deford CC, Scott JG, Schwartz LH, Perdue JJ, Terrell DR, Vesely SK, George JN. Depression and cognitive impairment following recovery from thrombotic thrombocytopenic purpura. Am J Hematol. 2015 Aug; 90(8):709-14. PMID: 25975932.
      View in: PubMed
    20. Reese JA, Bougie DW, Curtis BR, Terrell DR, Vesely SK, Aster RH, George JN. Drug-induced thrombotic microangiopathy: Experience of the Oklahoma Registry and the BloodCenter of Wisconsin. Am J Hematol. 2015 May; 90(5):406-10. PMID: 25639727.
      View in: PubMed
    21. Edgar CE, Terrell DR, Vesely SK, Wren JD, Dozmorov IM, Niewold TB, Brown M, Zhou F, Frank MB, Merrill JT, Kremer Hovinga JA, Lämmle B, James JA, George JN, Farris AD. Ribosomal and immune transcripts associate with relapse in acquired ADAMTS13-deficient thrombotic thrombocytopenic purpura. PLoS One. 2015; 10(2):e0117614. PMID: 25671313.
      View in: PubMed
    22. McClain RS, Terrell DR, Vesely SK, George JN. Plasma exchange complications in patients treated for thrombotic thrombocytopenia purpura-hemolytic uremic syndrome: 2011 to 2014. Transfusion. 2014 Dec; 54(12):3257-9. PMID: 25496391.
      View in: PubMed
    23. Al-Nouri ZL, Reese JA, Terrell DR, Vesely SK, George JN. Drug-induced thrombotic microangiopathy: a systematic review of published reports. Blood. 2015 Jan 22; 125(4):616-8. PMID: 25414441.
      View in: PubMed
    24. Lu KH, George JN, Vesely SK, Terrell DR. Management of primary immune thrombocytopenia, 2012: a survey of oklahoma hematologists-oncologists. Am J Med Sci. 2014 Mar; 347(3):190-4. PMID: 23462246.
      View in: PubMed
    25. Jiang Y, McIntosh JJ, Reese JA, Deford CC, Kremer Hovinga JA, Lämmle B, Terrell DR, Vesely SK, Knudtson EJ, George JN. Pregnancy outcomes following recovery from acquired thrombotic thrombocytopenic purpura. Blood. 2014 Mar 13; 123(11):1674-80. PMID: 24398329.
      View in: PubMed
    26. Reese JA, Nguyen LP, Buchanan GR, Curtis BR, Terrell DR, Vesely SK, George JN. Drug-induced thrombocytopenia in children. Pediatr Blood Cancer. 2013 Dec; 60(12):1975-81. PMID: 24038783.
      View in: PubMed
    27. Deford CC, Reese JA, Schwartz LH, Perdue JJ, Kremer Hovinga JA, Lämmle B, Terrell DR, Vesely SK, George JN. Multiple major morbidities and increased mortality during long-term follow-up after recovery from thrombotic thrombocytopenic purpura. Blood. 2013 Sep 19; 122(12):2023-9; quiz 2142. PMID: 23838348.
      View in: PubMed
    28. Reese JA, Muthurajah DS, Kremer Hovinga JA, Vesely SK, Terrell DR, George JN. Children and adults with thrombotic thrombocytopenic purpura associated with severe, acquired Adamts13 deficiency: comparison of incidence, demographic and clinical features. Pediatr Blood Cancer. 2013 Oct; 60(10):1676-82. PMID: 23729372.
      View in: PubMed
    29. Griffin D, Al-Nouri ZL, Muthurajah D, Ross JR, Ballard RB, Terrell DR, Vesely SK, George JN, Marques MB. First symptoms in patients with thrombotic thrombocytopenic purpura: what are they and when do they occur? Transfusion. 2013 Jan; 53(1):235-7. PMID: 23294213.
      View in: PubMed
    30. Wahl PM, Bohn RL, Terrell DR, George JN, Ewenstein B. Health care utilization of patients diagnosed with idiopathic thrombotic thrombocytopenic purpura in a commercially insured population in the United States. Transfusion. 2012 Jul; 52(7 Pt 2):1614-21. PMID: 22780943.
      View in: PubMed
    31. Terrell DR, Beebe LA, Vesely SK, Neas BR, Segal JB, George JN. Determining a definite diagnosis of primary immune thrombocytopenia by medical record review. Am J Hematol. 2012 Sep; 87(9):843-7. PMID: 22718340.
      View in: PubMed
    32. Terrell DR, Beebe LA, Neas BR, Vesely SK, Segal JB, George JN. Prevalence of primary immune thrombocytopenia in Oklahoma. Am J Hematol. 2012 Sep; 87(9):848-52. PMID: 22674643.
      View in: PubMed
    33. Som S, Deford CC, Kaiser ML, Terrell DR, Kremer Hovinga JA, Lämmle B, George JN, Vesely SK. Decreasing frequency of plasma exchange complications in patients treated for thrombotic thrombocytopenic purpura-hemolytic uremic syndrome, 1996 to 2011. Transfusion. 2012 Dec; 52(12):2525-32; quiz 2524. PMID: 22501034.
      View in: PubMed
    34. George JN, Terrell DR, Vesely SK, Kremer Hovinga JA, Lämmle B. Thrombotic microangiopathic syndromes associated with drugs, HIV infection, hematopoietic stem cell transplantation and cancer. Presse Med. 2012 Mar; 41(3 Pt 2):e177-88. PMID: 22244728.
      View in: PubMed
    35. Froehlich-Zahnd R, George JN, Vesely SK, Terrell DR, Aboulfatova K, Dong JF, Luken BM, Voorberg J, Budde U, Sulzer I, Lämmle B, Kremer Hovinga JA. Evidence for a role of anti-ADAMTS13 autoantibodies despite normal ADAMTS13 activity in recurrent thrombotic thrombocytopenic purpura. Haematologica. 2012 Feb; 97(2):297-303. PMID: 21993669.
      View in: PubMed
    36. Booth KK, Terrell DR, Vesely SK, George JN. Systemic infections mimicking thrombotic thrombocytopenic purpura. Am J Hematol. 2011 Sep; 86(9):743-51. PMID: 21850657.
      View in: PubMed
    37. Terrell DR, Motto DG, Kremer Hovinga JA, Lämmle B, George JN, Vesely SK. Blood group O and black race are independent risk factors for thrombotic thrombocytopenic purpura associated with severe ADAMTS13 deficiency. Transfusion. 2011 Oct; 51(10):2237-43. PMID: 21470236.
      View in: PubMed
    38. Newton JL, Reese JA, Watson SI, Vesely SK, Bolton-Maggs PH, George JN, Terrell DR. Fatigue in adult patients with primary immune thrombocytopenia. Eur J Haematol. 2011 May; 86(5):420-9. PMID: 21323737.
      View in: PubMed
    39. Terrell DR, Vesely SK, Kremer Hovinga JA, Lämmle B, George JN. Different disparities of gender and race among the thrombotic thrombocytopenic purpura and hemolytic-uremic syndromes. Am J Hematol. 2010 Nov; 85(11):844-7. PMID: 20799358.
      View in: PubMed
    40. Royer DJ, George JN, Terrell DR. Thrombocytopenia as an adverse effect of complementary and alternative medicines, herbal remedies, nutritional supplements, foods, and beverages. Eur J Haematol. 2010 May; 84(5):421-9. PMID: 20525061.
      View in: PubMed
    41. Wahl PM, Terrell DR, George JN, Rodgers JK, Uhl L, Cataland S, Bohn RL. Validation of claims-based diagnostic codes for idiopathic thrombotic thrombocytopenic purpura in a commercially-insured population. Thromb Haemost. 2010 Jun; 103(6):1203-9. PMID: 20352159.
      View in: PubMed
    42. Terrell DR, Beebe LA, Vesely SK, Neas BR, Segal JB, George JN. The incidence of immune thrombocytopenic purpura in children and adults: A critical review of published reports. Am J Hematol. 2010 Mar; 85(3):174-80. PMID: 20131303.
      View in: PubMed
    43. Kremer Hovinga JA, Vesely SK, Terrell DR, Lämmle B, George JN. Survival and relapse in patients with thrombotic thrombocytopenic purpura. Blood. 2010 Feb 25; 115(8):1500-11; quiz 1662. PMID: 20032506.
      View in: PubMed
    44. Guidry JA, Watson S, George JN, Vesely SK, Terrell DR. Addendum to corticosteroid side effects and risk for bleeding in immune thrombocytopenic purpura: patient perspectives. Eur J Haematol. 2009 Nov; 83(5):497-8. PMID: 19614752.
      View in: PubMed
    45. Bose P, Hussein KK, Terrell DR, Berger D, Rice L, George JN. Successful treatment of cyclic thrombocytopenia with thrombopoietin-mimetic agents: a report of two patients. Am J Hematol. 2009 Jul; 84(7):459-61. PMID: 19484732.
      View in: PubMed
    46. Terrell DR, Beebe LA, George JN, Vesely SK, Mold JW. Referral of patients with thrombocytopenia from primary care clinicians to hematologists. Blood. 2009 Apr 23; 113(17):4126-7. PMID: 19389893.
      View in: PubMed
    47. Benjamin M, Terrell DR, Vesely SK, Voskuhl GW, Dezube BJ, Kremer Hovinga JA, Lämmle B, George JN. Frequency and significance of HIV infection among patients diagnosed with thrombotic thrombocytopenic purpura. Clin Infect Dis. 2009 Apr 15; 48(8):1129-37. PMID: 19275493.
      View in: PubMed
    48. Guidry JA, George JN, Vesely SK, Kennison SM, Terrell DR. Corticosteroid side-effects and risk for bleeding in immune thrombocytopenic purpura: patient and hematologist perspectives. Eur J Haematol. 2009 Sep; 83(3):175-82. PMID: 19374704.
      View in: PubMed
    49. Kennedy AS, Lewis QF, Scott JG, Kremer Hovinga JA, Lämmle B, Terrell DR, Vesely SK, George JN. Cognitive deficits after recovery from thrombotic thrombocytopenic purpura. Transfusion. 2009 Jun; 49(6):1092-101. PMID: 19222817.
      View in: PubMed
    50. Swisher KK, Terrell DR, Vesely SK, Kremer Hovinga JA, Lämmle B, George JN. Clinical outcomes after platelet transfusions in patients with thrombotic thrombocytopenic purpura. Transfusion. 2009 May; 49(5):873-87. PMID: 19210323.
      View in: PubMed
    51. Nguyen L, Terrell DR, Duvall D, Vesely SK, George JN. Complications of plasma exchange in patients treated for thrombotic thrombocytopenic purpura. IV. An additional study of 43 consecutive patients, 2005 to 2008. Transfusion. 2009 Feb; 49(2):392-4. PMID: 19389220.
      View in: PubMed
    52. Lewis QF, Lanneau MS, Mathias SD, Terrell DR, Vesely SK, George JN. Long-term deficits in health-related quality of life after recovery from thrombotic thrombocytopenic purpura. Transfusion. 2009 Jan; 49(1):118-24. PMID: 18954401.
      View in: PubMed
    53. George JN, Terrell DR. Novel thrombopoietic agents: a new era for management of patients with thrombocytopenia. Haematologica. 2008 Oct; 93(10):1445-9. PMID: 18827261.
      View in: PubMed
    54. Karpac CA, Li X, Terrell DR, Kremer Hovinga JA, Lämmle B, Vesely SK, George JN. Sporadic bloody diarrhoea-associated thrombotic thrombocytopenic purpura-haemolytic uraemic syndrome: an adult and paediatric comparison. Br J Haematol. 2008 May; 141(5):696-707. PMID: 18422775.
      View in: PubMed
    55. George JN, Kremer Hovinga JA, Terrell DR, Vesely SK, Lämmle B. The Oklahoma Thrombotic Thrombocytopenic Purpura-Hemolytic Uremic Syndrome Registry: the Swiss connection. Eur J Haematol. 2008 Apr; 80(4):277-86. PMID: 18221388.
      View in: PubMed
    56. Ambadwar P, Duvall D, Wolf NJ, Terrell DR, Vesely SK, George JN. Support groups for patients who have recovered from thrombotic thrombocytopenic purpura. J Clin Apher. 2008; 23(5):168-9. PMID: 18785649.
      View in: PubMed
    57. George JN, Terrell DR, Swisher KK, Vesely SK. Lessons learned from the Oklahoma thrombotic thrombocytopenic purpura-hemolytic uremic syndrome registry. J Clin Apher. 2008; 23(4):129-37. PMID: 18618590.
      View in: PubMed
    58. Nguyen L, Li X, Duvall D, Terrell DR, Vesely SK, George JN. Twice-daily plasma exchange for patients with refractory thrombotic thrombocytopenic purpura: the experience of the Oklahoma Registry, 1989 through 2006. Transfusion. 2008 Feb; 48(2):349-57. PMID: 18028271.
      View in: PubMed
    59. Johnson KK, Duvall D, Gilcher RO, Smith JW, Forsberg JE, Terrell DR, Vesely SK, George JN. The Oklahoma Thrombotic Thrombocytopenic Purpura-Hemolytic Uremic Syndrome Registry: a community service. J Okla State Med Assoc. 2007 Jul; 100(7):273-8. PMID: 17896615.
      View in: PubMed
    60. Francis KK, Kalyanam N, Terrell DR, Vesely SK, George JN. Disseminated malignancy misdiagnosed as thrombotic thrombocytopenic purpura: A report of 10 patients and a systematic review of published cases. Oncologist. 2007 Jan; 12(1):11-9. PMID: 17227897.
      View in: PubMed
    61. Howard MA, Williams LA, Terrell DR, Duvall D, Vesely SK, George JN. Complications of plasma exchange in patients treated for clinically suspected thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Transfusion. 2006 Jan; 46(1):154-6. PMID: 16398746.
      View in: PubMed
    62. Terrell DR, Johnson KK, Vesely SK, George JN. Is immune thrombocytopenic purpura less common among black Americans? Blood. 2005 Feb 01; 105(3):1368-9. PMID: 15659620.
      View in: PubMed
    63. Vesely SK, Li X, McMinn JR, Terrell DR, George JN. Pregnancy outcomes after recovery from thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Transfusion. 2004 Aug; 44(8):1149-58. PMID: 15265118.
      View in: PubMed
    64. Kojouri K, Vesely SK, Terrell DR, George JN. Splenectomy for adult patients with idiopathic thrombocytopenic purpura: a systematic review to assess long-term platelet count responses, prediction of response, and surgical complications. Blood. 2004 Nov 01; 104(9):2623-34. PMID: 15217831.
      View in: PubMed
    65. George JN, Li X, McMinn JR, Terrell DR, Vesely SK, Selby GB. Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome following allogeneic HPC transplantation: a diagnostic dilemma. Transfusion. 2004 Feb; 44(2):294-304. PMID: 14962323.
      View in: PubMed
    66. Vesely SK, Perdue JJ, Rizvi MA, Terrell DR, George JN. Management of adult patients with persistent idiopathic thrombocytopenic purpura following splenectomy: a systematic review. Ann Intern Med. 2004 Jan 20; 140(2):112-20. PMID: 14734334.
      View in: PubMed
    67. George JN, Vesely SK, Terrell DR. The Oklahoma Thrombotic Thrombocytopenic Purpura-Hemolytic Uremic Syndrome (TTP-HUS) Registry: a community perspective of patients with clinically diagnosed TTP-HUS. Semin Hematol. 2004 Jan; 41(1):60-7. PMID: 14727260.
      View in: PubMed
    68. McMinn JR, Cohen S, Moore J, Lilly S, Parkhurst J, Tarantino MD, Terrell DR, George JN. Complete recovery from refractory immune thrombocytopenic purpura in three patients treated with etanercept. Am J Hematol. 2003 Jun; 73(2):135-40. PMID: 12749017.
      View in: PubMed
    69. McMinn JR, Thomas IA, Terrell DR, Duvall D, Vesely SK, George JN. Complications of plasma exchange in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: a study of 78 additional patients. Transfusion. 2003 Mar; 43(3):415-6. PMID: 12675731.
      View in: PubMed
    70. Howard MA, Hibbard AB, Terrell DR, Medina PJ, Vesely SK, George JN. Quinine allergy causing acute severe systemic illness: report of 4 patients manifesting multiple hematologic, renal, and hepatic abnormalities. Proc (Bayl Univ Med Cent). 2003 Jan; 16(1):21-6. PMID: 16278718.
      View in: PubMed
    71. Howard MA, Duvall D, Terrell DR, Christopher AT, Thomas I, Holloway N, Vesely SK, George JN. A support group for patients who have recovered from thrombotic thrombocytopenic purpura-hemolytic uremic syndrome (TTP-HUS): The six-year experience of the Oklahoma TTP-HUS Study Group. J Clin Apher. 2003; 18(1):16-20. PMID: 12717788.
      View in: PubMed
    Terrell's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description